SCHEMBL24729569

SCHEMBL24729569

Nc1cc(OCc2cn3cc(C4CC4)ccc3n2)ccn1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ METTL3 Q86U44 1/20 0.39
▸ KLKB1 P03952 8/20 0.37
▸ GRM5 P41594 5/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ NOS3 P29474 1/20 0.35
▸ NOS1 P29475 1/20 0.35
▸ NOS2 P35228 1/20 0.35
▸ KCNH2 Q12809 1/20 0.34
▸ SCN5A Q14524 1/20 0.34
▸ SCN9A Q15858 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24729570 0.86 SMN1; SMN2 (0.41) METTL3KLKB1GRM5SMN1; SMN2NPC1
SCHEMBL29958329 0.84 SMN1; SMN2 (0.42) METTL3KLKB1GRM5SMN1; SMN2NPC1
SCHEMBL24738256 0.84 KLKB1 (0.38) METTL3KLKB1GRM5SMN1; SMN2NPC1
SCHEMBL24729668 0.84 METTL3 (0.39) METTL3KLKB1SMN1; SMN2NPC1RAB9A
SCHEMBL29141754 0.82 METTL3 (0.41) METTL3KLKB1KDM4E
SCHEMBL24738257 0.82 METTL3 (0.39) METTL3KLKB1
SCHEMBL24729661 0.80 SMN1; SMN2 (0.46) METTL3KLKB1SMN1; SMN2NPC1RAB9A
SCHEMBL29958412 0.79 KLKB1 (0.36) METTL3KLKB1
SCHEMBL27033615 0.79 KLKB1 (0.36) METTL3KLKB1
SCHEMBL27030423 0.79 METTL3 (0.37) METTL3KLKB1GRM5SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117396473-A Imidazopyridinyl inhibitors of plasma kallikrein 武田药品工业株式会社 2024-01-12 — — CN disclosed
CN-117396474-A Plasma kallikrein inhibitors 武田药品工业株式会社 2024-01-12 — — CN disclosed
WO-2022197755-A1 IMIDAZOPYRIDINYL INHIBITORS OF PLASMA KALLIKREIN SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 — — WO disclosed
Send feedback